Mary Lou Jepsen, PhD is the Founder, CEO, and Chairman of Openwater.health, a company that develops medical technology integrating semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level. Openwater aims to make hospital-grade medical care accessible worldwide. The company's platform combines infrared imaging, ultrasound, and electromagnetic fields. Openwater collaborates with leading institutions to validate its technology and drive healthcare innovation. Using open-source principles and consumer electronics manufacturing, Openwater seeks to reduce medical device development time and costs. Jepsen has been named to Time Magazine's 100 Most Influential People and CNN's Top 10 Thinkers. A former executive at Facebook, Oculus, Google and Intel, Jepsen founded four hardware companies including One Laptop per Child (OLPC). Jepsen is a former MIT Professor with 250 published or issued patents.
If you rely on federal grants as your sole means of support, you’re tying your destiny to forces outside your control. There are other roads to success in health and medical research. By pursuing them, you might gain more freedom, fewer administrative hurdles, and the chance to save lives faster.
We are living in a moment when many realize that collaboration yields better, faster and more affordable advances. Open source also enables the potential for bigger profits and revenue. What’s in reach: a small amount of money paid for treatments across millions of people, rather than expensive lifesaving treatments only for the few who can afford them.
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
The current model of siloed, proprietary development is failing us. It's slow, expensive, and often results in technologies that never see the light of day. What if, instead, we embraced an open-source approach to medical device innovation?